Avanti Polar Lipids

Avanti Polar Lipids is a leader in the development and manufacturing of high-purity lipids and associated pharmaceutical services that are utilized as drug delivery solutions for complex therapeutic drugs and next generation mRNA vaccines. Throughout Avanti's history, the company has been an innovator in lipid-based products and applications for the life sciences markets and currently serves thousands of leading biopharmaceutical companies and researchers around the world. The company has two primary revenue streams in research products and pharmaceutical services. The company also offers pharmaceutical services where it leverages its lipid-based expertise to develop and supply drug delivery solutions for complex therapeutics. Avanti provides a comprehensive range of services from formulation and analytical services through cGMP manufacturing of synthetic lipids and adjuvants for clinical and commercial applications.

has been acquired by

Pharmaceutical Ingredients & R&D

Situation

BlackArch was retained by Avanti to serve as its exclusive financial advisor.

BlackArch’s Customized Solution

The transaction continues BlackArch’s significant momentum in the pharmaceutical services and healthcare sectors and is representative of the firm’s focus on providing dedicated M&A advisory services to market-leading businesses.

Outcome

Avanti was acquired by Croda International plc (OTCMKTS: COIHY).

Industries:

Life Science & Healthcare

Location:

Alabaster, AL

Transaction type:

Sellside Advisory